Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen (PSA) level and low-risk disease, according to a report in the July 26 issue of Archives of Internal Medicine.

• Previous Entry: Canon’s second quarterly profit quadruples on global demand for cameras, office equipment
• Next Entry: First step toward electronic DNA sequencing: Translocation through graphene nanopores